| Stereochemistry | RACEMIC |
| Molecular Formula | C25H19N3O4 |
| Molecular Weight | 425.4361 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC=C(C=C1)C2=NNC3=C2C(N(C3=O)C4=CC=C(C=C4)C(O)=O)C5=CC(O)=CC=C5
InChI
InChIKey=VGUQVYZXABOXCX-UHFFFAOYSA-N
InChI=1S/C25H19N3O4/c1-14-5-7-15(8-6-14)21-20-22(27-26-21)24(30)28(18-11-9-16(10-12-18)25(31)32)23(20)17-3-2-4-19(29)13-17/h2-13,23,29H,1H3,(H,26,27)(H,31,32)
| Molecular Formula | C25H19N3O4 |
| Molecular Weight | 425.4361 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 0.15 µM [IC50] | |||
| 4.8 null [pIC50] | |||
| 5.0 null [pIC50] |
